$190.03 0.4%
Price vs. AI Score (Last 150 days)
Data gathered: December 1

Data Bits

Data Bits Value / Change Benchmark
Job Posts 131 0%
Sentiment 59 -1.7%
Webpage traffic 53,000 -39.1%
Employee Rating 76 0%
Google Trends 55 -5.2%
Linkedin Employees 2,782 N/A
Patents 259 0.4%
4chan Mentions 0% N/A
Facebook Engagement 7,354 -12.6%
Facebook followers 76,624 0%
Stocktwits Mentions 3 -25%
Stocktwits Subscribers 1,673 -0.1%
Twitter Followers 7,667 -0%
Instagram Followers 43,534 0%
News Mentions 0%
Reddit Mentions 0%
Business outlook 73 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.

Price $190.03
Target Price Sign up
Market Cap $13.2B
Dividend Yield 0.0068
Industry Medical Devices

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '23433M139M293M52M67M
Q2 '23397M132M265M27M41M
Q1 '23358M118M241M24M36M
Q4 '22370M152M217M17M33M
Q3 '22341M153M188M-5.2M5.4M

Insider Transactions

Petrovic Shacey filed to sell 2,567 shares at $164.3.
November 14 '23
Singh Prem filed to buy 4,032 shares at $168.9.
September 21 '23
Hollingshead James filed to buy 34,177 shares at $181.4.
August 29 '23
McMillan Wayde D. filed to sell 21,477 shares at $282.9.
July 6 '23
Manea Dan filed to sell 4,522 shares at $290.
June 21 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.